Biomarker ID | 1668 |
PMID | 25847734 |
Year | 2015 |
Biomarker | p2PSA |
Biomarker Basis | Concentration Based (pg/mL) |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Downregulated in Primary and Metastatic PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | PCa Vs No PCa |
Type of Biomarker | Diagnostic |
Cohort | 250 patients, 112 with Prostate cancer and 138 with No prostate cancer were selected for analysis |
Senstivity | NA |
Specificity | NA |
AUC | 0.630 (95% CI: 0.560-0.699) |
Accuracy | NA |
Level Of Significance | p<0.001 |
Method Used | Immunoassays |
Clinical | No |
Remarks | 10 fold cross validation was performed |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |